Skip to content

Dr. G. Gouwy

Active
Private limited company (pre-2019)founded 1992active for 33 yearsTwee Dreven 18, 9830 Sint-Martens-Latem, BelgiumKBO/BCE: BE 0448.720.218
Summary

The annual accounts of Dr. G. Gouwy for financial year 2025 show a net loss of 96% of the equity at the start of that year. The 2025 annual accounts show equity of €1,601 and a net result of -€40,158. Equity has been shrinking by about 23% per year since 2018. If that trend continues, it turns negative around financial year 2026. Its solvency ranks better than 9% of 783 sector peers (NACE 86, financial year 2025). The company has been active since 1992 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Official details

Source: KBO
Status
Active since 17-11-1992 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Joint committees
100 Aanvullend Paritair Comité voor de werklieden
200 Aanvullend Paritair Comité voor de bedienden · annual accounts 2025
Establishment unit
2.174.902.524 9830 Sint-Martens-Latem, since 01-01-2008
Financial year end
31 December
Peppol
Reachable since 04-12-2025

Financial position

52 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
-€8,683
Loss
€40,158
▲ 85.8%
Equity
€1,601
▼ 96.2%
Total assets
€118,569
▼ 29.4%
Employees on 31-12-2025
1
=
Score breakdownraises riskCapped at 59: a net loss of at least half of total assets or of the equity at the start of the financial yearLoss of €40,158, the second in a row (financial year 2025)lowers riskSector: Human health activities (NACE 86)Size: 0.4 FTE, total assets €118,569Founded in 1992Show the evidence

Checked score

Score 2025
52 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 3% of micro companies in human health (NACE 86)
A net loss of at least half of total assets or of the equity at the start of the financial year caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Weak
Solvency 26-24
equity 1.4% of total assets
Liquidity 15-35
short-term debt 98.6% · cash 12.2%
Profitability 0-5
return on assets -33.9%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026highest value 09-2026: 0.2%● unchanged vs 08-2026highest value 10-2026: 0.2%● unchanged vs 09-2026highest value 11-2026: 0.2%● unchanged vs 10-2026highest value
No publishable credit limit, so credit only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity is tight, with a current ratio of 1.01 (1.33 in 2024), below the usual 1.5. Short-term debt is 98.6% and cash 12.2% of total assets. 98.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 6% of them on solvency, 2% on liquidity, 1% on profitability and 4% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Seven signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Loss of €40,158, the second in a row (financial year 2025)
NBB · annual accounts
lowers risk · Size: 0.4 FTE, total assets €118,569
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Founded in 1992
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€40,158
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 9% of 783 sector peers (2025).
NBB · sector comparison
Position among 783 sector peers
Solvency
better than 9%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
24 days early
2024
17 days early
2023
16 days early
2022
on the day
2021
12 days early
2020
4 days early
2019
185 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 16 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 16 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Risk: 5 loss-making years in a rowloss in financial year 2025 -€40,158 View
  • Caution: Less equity than 91% of companies in human healthsector median €430,191 · 782 companies €1,601 View
  • Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View

Recent changes

  1. · Gazette deed Incorporation
All 16 events

Comparable companies

These companies have the same main activity as Dr. G. Gouwy: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €92,700 and €166,000, founded between 1990 and 1999.

CompanyTotal assetsGross margin
Dr. G. Gouwy Sint-Martens-Latem€118,569-€8,683
D.G.M.E. Chaumont-Gistoux€108,530-€23,136
VAN DIJCK, KEEL-, NEUS EN OORZIEKTEN Genk€98,544-€5,375
DR. GUY SMET Nieuwpoort€145,521-€14,864
Orthochir Waterloo€92,695-€10,311
ANESTEPSY Tubize€101,890-€1,784
C.d.N. CONSULTING Visé€166,009-€843
Full comparison

Key facts about Dr. G. Gouwy

What is the company number of Dr. G. Gouwy?
The company number of Dr. G. Gouwy is 0448.720.218. The VAT number is the same number with BE in front: BE 0448.720.218.
Where is Dr. G. Gouwy based?
The registered office is at Twee Dreven 18, 9830 Sint-Martens-Latem.Company details
What does Dr. G. Gouwy do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. G. Gouwy?
The legal form of Dr. G. Gouwy is Private limited company (pre-2019) (BVBA).
When was Dr. G. Gouwy founded?
Dr. G. Gouwy was founded on 17-11-1992.
Is Dr. G. Gouwy still active?
Yes, Dr. G. Gouwy is an active enterprise in the KBO register.
How many employees does Dr. G. Gouwy have?
Dr. G. Gouwy had an average of 0.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Dr. G. Gouwy fall under?
In its 2025 annual accounts, Dr. G. Gouwy states joint committees 100 (Aanvullend Paritair Comité voor de werklieden) and 200 (Aanvullend Paritair Comité voor de bedienden).
What is the turnover of Dr. G. Gouwy?
The annual accounts for financial year 2025 state no turnover.
Is Dr. G. Gouwy profitable?
In financial year 2025, Dr. G. Gouwy made a loss of €40,158.
Where can I find the annual accounts of Dr. G. Gouwy?
Dr. G. Gouwy filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. G. Gouwy due?
Dr. G. Gouwy must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.